ASRT
ASRT
NASDAQ · Pharmaceuticals

Assertio Holdings Inc

$23.50
+0.02 (+0.09%)
Financial Highlights (FY 2026)
Revenue
119.81M
Net Income
-30,655,937
Gross Margin
70.2%
Profit Margin
-25.6%
Rev Growth
-8.7%
D/E Ratio
0.42
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 70.2% 70.2% 61.1% 61.1%
Operating Margin -25.0% -22.5% 27.7% 26.1%
Profit Margin -25.6% -24.3% 24.0% 28.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 119.81M 131.28M 46.50M 50.98M
Gross Profit 84.09M 92.15M 28.43M 31.17M
Operating Income -29,988,472 -29,574,429 12.90M 13.28M
Net Income -30,655,937 -30,232,679 11.15M 14.28M
Gross Margin 70.2% 70.2% 61.1% 61.1%
Operating Margin -25.0% -22.5% 27.7% 26.1%
Profit Margin -25.6% -24.3% 24.0% 28.0%
Rev Growth -8.7% -8.7% +24.8% -5.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 22.32M 22.32M 22.71M 25.70M
Total Equity 53.61M 53.61M 31.18M 30.14M
D/E Ratio 0.42 0.42 0.73 0.85
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 255.3K 265.7K 17.15M 17.67M
Free Cash Flow 10.93M 11.61M